These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 30642437)

  • 1. The National Institute on Aging and Alzheimer's Association research framework: A commentary from the Cochrane Dementia and Cognitive Improvement Group.
    McCleery J; Flicker L; Richard E; Quinn TJ
    Alzheimers Dement; 2019 Jan; 15(1):179-181. PubMed ID: 30642437
    [No Abstract]   [Full Text] [Related]  

  • 2. A methodological critique of the National Institute of Aging and Alzheimer's Association Guidelines for Alzheimer's disease, dementia, and mild cognitive impairments.
    Garrett MD; Valle R
    Dementia (London); 2016 Mar; 15(2):239-54. PubMed ID: 24662500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When is Alzheimer's not dementia-Cochrane commentary on The National Institute on Ageing and Alzheimer's Association Research Framework for Alzheimer's Disease.
    McCleery J; Flicker L; Richard E; Quinn TJ
    Age Ageing; 2019 Mar; 48(2):174-177. PubMed ID: 30329009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 2018 NIA-AA research framework: Recommendation and comments.
    Louie R
    Alzheimers Dement; 2019 Jan; 15(1):182-183. PubMed ID: 30642438
    [No Abstract]   [Full Text] [Related]  

  • 5. Causes and Patterns of Dementia: An Update in the Era of Redefining Alzheimer's Disease.
    James BD; Bennett DA
    Annu Rev Public Health; 2019 Apr; 40():65-84. PubMed ID: 30642228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable.
    Knopman DS; Haeberlein SB; Carrillo MC; Hendrix JA; Kerchner G; Margolin R; Maruff P; Miller DS; Tong G; Tome MB; Murray ME; Nelson PT; Sano M; Mattsson N; Sultzer DL; Montine TJ; Jack CR; Kolb H; Petersen RC; Vemuri P; Canniere MZ; Schneider JA; Resnick SM; Romano G; van Harten AC; Wolk DA; Bain LJ; Siemers E
    Alzheimers Dement; 2018 Apr; 14(4):563-575. PubMed ID: 29653607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The National Institute on Aging-Alzheimer's Association Framework on Alzheimer's disease: Application to clinical trials.
    Cummings J
    Alzheimers Dement; 2019 Jan; 15(1):172-178. PubMed ID: 29936146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revisiting the framework of the National Institute on Aging-Alzheimer's Association diagnostic criteria.
    Carrillo MC; Dean RA; Nicolas F; Miller DS; Berman R; Khachaturian Z; Bain LJ; Schindler R; Knopman D;
    Alzheimers Dement; 2013 Sep; 9(5):594-601. PubMed ID: 24007744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of International Working Group criteria and National Institute on Aging-Alzheimer's Association criteria for Alzheimer's disease.
    Visser PJ; Vos S; van Rossum I; Scheltens P
    Alzheimers Dement; 2012 Nov; 8(6):560-3. PubMed ID: 23102126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspective: Clinical relevance of the dichotomous classification of Alzheimer's disease biomarkers: Should there be a "gray zone"?
    McRae-McKee K; Udeh-Momoh CT; Price G; Bajaj S; de Jager CA; Scott D; Hadjichrysanthou C; McNaughton E; Bracoud L; Ahmadi-Abhari S; de Wolf F; Anderson RM; Middleton LT;
    Alzheimers Dement; 2019 Oct; 15(10):1348-1356. PubMed ID: 31564609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease".
    Korczyn AD
    Alzheimers Dement; 2011 May; 7(3):333-4. PubMed ID: 21575875
    [No Abstract]   [Full Text] [Related]  

  • 12. Mapping CSF biomarker profiles onto NIA-AA guidelines for Alzheimer's disease.
    Alexopoulos P; Roesler J; Thierjung N; Werle L; Buck D; Yakushev I; Gleixner L; Kagerbauer S; Ortner M; Grimmer T; Kübler H; Martin J; Laskaris N; Kurz A; Perneczky R
    Eur Arch Psychiatry Clin Neurosci; 2016 Oct; 266(7):587-97. PubMed ID: 26253588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Alzheimer's disease translational research programs at the National Institute on Aging.
    Petanceska S; Ryan L; Silverberg N; Buckholtz N
    Alzheimers Dement; 2009 Mar; 5(2):130-2. PubMed ID: 19328442
    [No Abstract]   [Full Text] [Related]  

  • 14. National Institute on Aging - Alzheimer's Association Research Framework lays the groundwork for deeper understanding of Alzheimer's disease.
    Knopman DS; Siemers ER; Bain LJ; Hendrix JA; Carrillo MC
    Alzheimers Dement; 2018 Feb; 14(2):261-262. PubMed ID: 29413643
    [No Abstract]   [Full Text] [Related]  

  • 15. NIA commentary on the NIA-AA Research Framework: Towards a biological definition of Alzheimer's disease.
    Silverberg N; Elliott C; Ryan L; Masliah E; Hodes R
    Alzheimers Dement; 2018 Apr; 14(4):576-578. PubMed ID: 29653608
    [No Abstract]   [Full Text] [Related]  

  • 16. Common Alzheimer's Disease Research Ontology: National Institute on Aging and Alzheimer's Association collaborative project.
    Refolo LM; Snyder H; Liggins C; Ryan L; Silverberg N; Petanceska S; Carrillo MC
    Alzheimers Dement; 2012 Jul; 8(4):372-5. PubMed ID: 22748941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revised criteria for diagnosis of Alzheimer's disease: National Institute on Aging-Alzheimer's Association diagnostic guidelines for Alzheimer's disease.
    Khachaturian ZS
    Alzheimers Dement; 2011 May; 7(3):253-6. PubMed ID: 21575869
    [No Abstract]   [Full Text] [Related]  

  • 18. Commentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease." Addressing the challenge of Alzheimer's disease in the 21st century.
    Herrup K
    Alzheimers Dement; 2011 May; 7(3):335-7. PubMed ID: 21575876
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
    Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supportive CSF biomarker evidence to enhance the National Institute on Aging-Alzheimer's Association criteria for diagnosis of Alzheimer's type dementia--a study from Southern India.
    Huded CB; Bharath S; Chandra SR; Sivakumar PT; Varghese M; Subramanian S
    Asian J Psychiatr; 2015 Feb; 13():44-7. PubMed ID: 25468261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.